Frolov A - Search Results

1

Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.

Ayala G, Morello M, Frolov A, You S, Li R, Rosati F, Bartolucci G, Danza G, Adam RM, Thompson TC, Lisanti MP, Freeman MR, Vizio DD. Ayala G, et al. Among authors: frolov a. J Pathol. 2013 Sep;231(1):77-87. doi: 10.1002/path.4217. Epub 2013 Jul 8. J Pathol. 2013. PMID: 23729330 Free PMC article.

2

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.

Li R, Wheeler T, Dai H, Frolov A, Thompson T, Ayala G. Li R, et al. Among authors: frolov a. Am J Surg Pathol. 2004 Jul;28(7):928-34. doi: 10.1097/00000478-200407000-00013. Am J Surg Pathol. 2004. PMID: 15223964

3

Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.

Li R, Erdamar S, Dai H, Wheeler TM, Frolov A, Scardino PT, Thompson TC, Ayala GE. Li R, et al. Among authors: frolov a. Hum Pathol. 2007 Oct;38(10):1501-7. doi: 10.1016/j.humpath.2007.02.016. Epub 2007 Jun 26. Hum Pathol. 2007. PMID: 17597184 Free PMC article.

4

Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.

Yang G, Addai J, Wheeler TM, Frolov A, Miles BJ, Kadmon D, Thompson TC. Yang G, et al. Among authors: frolov a. Hum Pathol. 2007 Nov;38(11):1688-95. doi: 10.1016/j.humpath.2007.03.024. Epub 2007 Aug 17. Hum Pathol. 2007. PMID: 17707459

5

Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.

Ayala GE, Muezzinoglu B, Hammerich KH, Frolov A, Liu H, Scardino PT, Li R, Sayeeduddin M, Ittmann MM, Kadmon D, Miles BJ, Wheeler TM, Rowley DR. Ayala GE, et al. Among authors: frolov a. Am J Pathol. 2011 Jan;178(1):79-87. doi: 10.1016/j.ajpath.2010.09.042. Epub 2010 Dec 23. Am J Pathol. 2011. PMID: 21224046 Free PMC article.

6

Cellular interactions of the phosphorylated form of AKT in prostate cancer.

Hammerich KH, Frolov A, Li R, Ittmann M, Ayala GE. Hammerich KH, et al. Among authors: frolov a. Hum Pathol. 2017 May;63:98-109. doi: 10.1016/j.humpath.2017.02.014. Epub 2017 Mar 11. Hum Pathol. 2017. PMID: 28300578

7

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

Yang G, Ayala G, De Marzo A, Tian W, Frolov A, Wheeler TM, Thompson TC, Harper JW. Yang G, et al. Among authors: frolov a. Clin Cancer Res. 2002 Nov;8(11):3419-26. Clin Cancer Res. 2002. PMID: 12429629

8

Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.

Tahir SA, Ren C, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM, Thompson TC. Tahir SA, et al. Among authors: frolov a. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3653-9. Clin Cancer Res. 2003. PMID: 14506154

9

Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.

Li R, Younes M, Wheeler TM, Scardino P, Ohori M, Frolov A, Ayala G. Li R, et al. Among authors: frolov a. Prostate. 2004 Feb 1;58(2):193-9. doi: 10.1002/pros.10321. Prostate. 2004. PMID: 14716745

10

Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival.

McAlhany SJ, Ayala GE, Frolov A, Ressler SJ, Wheeler TM, Watson JE, Collins C, Rowley DR. McAlhany SJ, et al. Among authors: frolov a. Prostate. 2004 Oct 1;61(2):182-91. doi: 10.1002/pros.20085. Prostate. 2004. PMID: 15305341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

835 results

Search Page

Filters